CN101028283A - 岩藻聚糖在治疗粘连、关节炎和牛皮癣中的用途 - Google Patents

岩藻聚糖在治疗粘连、关节炎和牛皮癣中的用途 Download PDF

Info

Publication number
CN101028283A
CN101028283A CNA200710096370XA CN200710096370A CN101028283A CN 101028283 A CN101028283 A CN 101028283A CN A200710096370X A CNA200710096370X A CN A200710096370XA CN 200710096370 A CN200710096370 A CN 200710096370A CN 101028283 A CN101028283 A CN 101028283A
Authority
CN
China
Prior art keywords
fucoidan
pharmaceutical composition
use according
medicament
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200710096370XA
Other languages
English (en)
Chinese (zh)
Inventor
J·K·杰克逊
H·M·伯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of CN101028283A publication Critical patent/CN101028283A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA200710096370XA 2001-08-29 2002-08-29 岩藻聚糖在治疗粘连、关节炎和牛皮癣中的用途 Pending CN101028283A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31536201P 2001-08-29 2001-08-29
US60/315,362 2001-08-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNB028166930A Division CN1319540C (zh) 2001-08-29 2002-08-29 岩藻聚糖在治疗粘连、关节炎和牛皮癣中的用途

Publications (1)

Publication Number Publication Date
CN101028283A true CN101028283A (zh) 2007-09-05

Family

ID=23224048

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA200710096370XA Pending CN101028283A (zh) 2001-08-29 2002-08-29 岩藻聚糖在治疗粘连、关节炎和牛皮癣中的用途
CNB028166930A Expired - Fee Related CN1319540C (zh) 2001-08-29 2002-08-29 岩藻聚糖在治疗粘连、关节炎和牛皮癣中的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNB028166930A Expired - Fee Related CN1319540C (zh) 2001-08-29 2002-08-29 岩藻聚糖在治疗粘连、关节炎和牛皮癣中的用途

Country Status (15)

Country Link
US (3) US6812220B2 (enExample)
EP (1) EP1420801B1 (enExample)
JP (2) JP4758063B2 (enExample)
KR (2) KR100910246B1 (enExample)
CN (2) CN101028283A (enExample)
AT (1) ATE376835T1 (enExample)
AU (1) AU2002325113B2 (enExample)
CA (1) CA2458853C (enExample)
DE (1) DE60223262T2 (enExample)
DK (1) DK1420801T3 (enExample)
ES (1) ES2295386T3 (enExample)
MX (1) MXPA04001876A (enExample)
NZ (2) NZ532015A (enExample)
PT (1) PT1420801E (enExample)
WO (1) WO2003018033A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102665733A (zh) * 2009-07-27 2012-09-12 Arc医疗设备股份有限公司 用于治疗纤维性粘连和其它疾病的包含改性岩藻多糖的药物组合物
CN111617030A (zh) * 2020-05-22 2020-09-04 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632456B1 (en) * 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
JP2006511475A (ja) * 2002-09-18 2006-04-06 トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア 脈絡膜新生血管症の抑制方法
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
WO2004078210A1 (ja) * 2003-03-06 2004-09-16 Takashi Muramatsu 開腹手術後の癒着の予防剤
BRPI0418384A (pt) * 2003-05-30 2007-06-26 Arc Pharmaceuticals Inc composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
WO2005027906A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US20070238677A1 (en) * 2004-03-17 2007-10-11 Locomogene, Inc. Pharmaceutical Composition Containing Hshrd3
CN101052684B (zh) * 2004-07-09 2014-02-12 克利夫兰临床基金会 羟基苯交联大分子网络及其应用
ES2729826T3 (es) * 2004-09-23 2019-11-06 Arc Medical Devices Inc Composiciones farmacéuticas y métodos relacionados para inhibir adherencias fibrosas o enfermedad inflamatoria usando fucanos con bajo contenido de sulfato
GB2438544A (en) 2005-02-09 2007-11-28 Cooper Internat Corp Liquid formulations for treatment of diseases or conditions
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
CA2595564C (en) * 2005-02-16 2015-03-31 Md Bioalpha Co., Ltd. Use of .beta.-lapachone and related naphthoquinones in the treatment of amp-activated protein kinase (ampk) mediated disorders
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US7666448B2 (en) * 2005-03-18 2010-02-23 Sakura Properties, Llc Skin cleansing article
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US7776365B2 (en) * 2005-03-18 2010-08-17 Sakura Properties, Llc Article with skin protecting and moisturizing compound
US20060210514A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin protection and moisturizing compositions and method of making the same
US20060210496A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Compositions for skin protection from ultraviolet damage
CA2851079A1 (en) 2005-04-15 2006-10-26 Albert Einstein College Of Medicine Of Yeshiva University Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
US20070003669A1 (en) * 2005-06-02 2007-01-04 Troy Kearl Fucoidan delivery system
WO2007028256A2 (en) * 2005-09-09 2007-03-15 Les Biotechnologies Oceanova Inc. Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
CA2635797C (en) 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
FR2897538B1 (fr) 2006-02-23 2008-05-02 Univ Paris Descartes Utilisation de fucanes a des fins de greffe, d'ingenierie et de regeneration osseuses
CN101443004B (zh) 2006-03-23 2013-03-06 参天制药株式会社 用于与血管通透性有关的疾病或病症的制剂
JP4814677B2 (ja) * 2006-03-31 2011-11-16 株式会社荏原製作所 基板保持装置および研磨装置
EP2043685B1 (en) 2006-07-03 2015-12-23 Genmab A/S Prevention of rash in patients undergoing anti-egfr therapy
US8080260B2 (en) 2008-02-13 2011-12-20 The Cleveland Clinic Foundation Molecular enhancement of extracellular matrix and methods of use
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
EP2300042A4 (en) 2008-04-30 2012-05-02 Cleveland Clinic Foundation COMPOSITIONS AND METHODS FOR TREATING URINARY INCONTINENCE
US20120071439A1 (en) * 2009-03-25 2012-03-22 Saburo Minami Cartilage production promoter and prophylactic or therapeutic agent for diseases associated with cartilage damage
KR101528265B1 (ko) * 2010-04-16 2015-06-11 코웨이 주식회사 베타-라파콘을 유효성분으로 포함하는 주름개선용 화장료 조성물
CA2838793C (en) * 2011-07-19 2019-08-06 Baxter International Inc. Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
EP3258932B1 (en) * 2015-02-16 2024-08-07 Lasserre, Gilles Henri Composition for prevention or treatment of cutaneous disorder
JP7160683B2 (ja) 2016-04-29 2022-10-25 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 術後癒着の予防及び治療のための方法及び組成物
SG11202100393TA (en) 2018-07-27 2021-02-25 Arc Medical Devices Inc Highly purified fucans for the treatment of fibrous adhesions
US12186334B2 (en) 2018-07-27 2025-01-07 ARC Medical Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
MX2021000866A (es) 2019-03-05 2021-06-15 Arc Medical Devices Inc Sistemas y metodos para la filtracion de flujo tangencial de composiciones viscosas.
WO2025166450A1 (en) * 2024-02-05 2025-08-14 ARC Medical Inc. Compositions, devices, systems and methods relating to improvement of range of motion in joints

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971848A (en) * 1970-12-21 1976-07-27 Kimitsu Chemical Laboratory Co. Ltd. Lubricating composition for mucosa or epidermis
JPS58147064A (ja) 1982-02-25 1983-09-01 Fuji Electric Co Ltd トランジスタ
EP0293826A3 (en) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
JPS6431707A (en) 1987-07-28 1989-02-02 Nikko Chemicals Dermal agent for external use
JPH0714850B2 (ja) 1987-09-29 1995-02-22 喜郎 板谷 化粧料
JPH01313433A (ja) 1988-06-13 1989-12-18 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
JP2853165B2 (ja) * 1989-05-29 1999-02-03 味の素株式会社 体組織癒着防止膜
FR2648463B1 (fr) * 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention
US6096722A (en) * 1990-08-14 2000-08-01 Isis Pharmaceuticals Inc. Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JP3403496B2 (ja) 1993-09-24 2003-05-06 株式会社ヤクルト本社 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤
JP3545789B2 (ja) * 1993-09-30 2004-07-21 味の素ファルマ株式会社 腹腔内癒着防止剤
FR2772618B1 (fr) 1997-12-18 2000-02-18 Ifremer Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
CA2354863A1 (en) * 1998-10-02 2000-04-13 University Of Florida Prevention of adhesions
JP4267106B2 (ja) * 1998-10-15 2009-05-27 株式会社クラレ 癒着防止用材料
JP2001052309A (ja) 1999-08-06 2001-02-23 Alps Electric Co Ltd 薄膜磁気ヘッドおよびその製造方法
SE0001631D0 (sv) * 2000-05-04 2000-05-04 Sahltech Ab New use

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102665733A (zh) * 2009-07-27 2012-09-12 Arc医疗设备股份有限公司 用于治疗纤维性粘连和其它疾病的包含改性岩藻多糖的药物组合物
CN102665733B (zh) * 2009-07-27 2016-08-10 Arc医疗设备股份有限公司 用于治疗纤维性粘连和其它疾病的包含改性岩藻多糖的药物组合物
CN106176798A (zh) * 2009-07-27 2016-12-07 Arc医疗设备股份有限公司 用于治疗纤维性粘连和其它疾病的包含改性岩藻多糖的药物组合物
CN111617030A (zh) * 2020-05-22 2020-09-04 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用

Also Published As

Publication number Publication date
ATE376835T1 (de) 2007-11-15
NZ532015A (en) 2006-12-22
JP4758063B2 (ja) 2011-08-24
HK1066482A1 (en) 2005-03-24
EP1420801B1 (en) 2007-10-31
KR20040032992A (ko) 2004-04-17
WO2003018033A1 (en) 2003-03-06
KR100910246B1 (ko) 2009-07-31
US20050119216A1 (en) 2005-06-02
US6812220B2 (en) 2004-11-02
ES2295386T3 (es) 2008-04-16
US7163930B2 (en) 2007-01-16
JP2005508893A (ja) 2005-04-07
CN1319540C (zh) 2007-06-06
KR20090019926A (ko) 2009-02-25
CA2458853A1 (en) 2003-03-06
DE60223262D1 (de) 2007-12-13
AU2002325113B2 (en) 2006-10-26
EP1420801A1 (en) 2004-05-26
PT1420801E (pt) 2008-01-17
CA2458853C (en) 2010-10-19
JP2009280597A (ja) 2009-12-03
US20050074496A1 (en) 2005-04-07
US20030064958A1 (en) 2003-04-03
DK1420801T3 (da) 2008-03-03
NZ547609A (en) 2008-07-31
DE60223262T2 (de) 2008-08-14
MXPA04001876A (es) 2004-06-15
CN1547478A (zh) 2004-11-17

Similar Documents

Publication Publication Date Title
CN1319540C (zh) 岩藻聚糖在治疗粘连、关节炎和牛皮癣中的用途
AU2002325113A1 (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
Kheilnezhad et al. A review: progress in preventing tissue adhesions from a biomaterial perspective
EP1809303B1 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
US20080124400A1 (en) Microparticles With High Loadings Of A Bioactive Agent
JP2007504273A (ja) 種々の作用剤を用いた、線維性癒着の抑制に関する医薬組成物及び方法
JP2007504273A5 (enExample)
US20070238697A1 (en) Pharmaceutical compositions and methods relating to fucans
AU2007200318B2 (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
HK1066482B (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
HK1108566A (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
EP1870105A1 (en) Use of fucans in the treatment of psoriasis
US20170252367A1 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1108566

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070905

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1108566

Country of ref document: HK